Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
Hematologic Oncology Update
00:00
Comparing CAR-T Therapies and Visual Assessments in Oncology
This chapter explores the efficacy and toxicity profiles of two CAR-T therapies, Anetacel and Siltacel, highlighting the safety advantages of Anetacel for multiple myeloma patients. It also discusses the practical implications of visual activity assessments in oncology and future patient evaluation methods.
Transcript
Play full episode
